Developer docs
API playgroundTry for free, no card

Search company profiles

Aerobiotix

Full company profile

uuid0002o33

Namestring
Aerobiotix
Legal namestring
Aerobiotix USA, LLC
Websiteurl
aerobiotix.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Aerobiotix is a medical device company founded in 2013 and headquartered in Miamisburg, Ohio, that develops air disinfection systems for healthcare facilities. The company targets hospital-acquired infection (HAI) reduction through continuous air decontamination in operating rooms, intensive care units, and other clinical environments. Its installed base spans large integrated delivery networks (IDNs), academic medical centers, and federal healthcare facilities, including the VA health system.

The company's flagship product is the Illuvia Sense system, an FDA-registered Class II medical device that combines high-efficiency particulate air (HEPA) filtration with ultraviolet germicidal irradiation (UVGI) inside a proprietary Intraviolet photolytic chamber. The platform continuously monitors air quality via onboard sensors and is engineered to inactivate airborne pathogens without disrupting clinical workflows. Aerobiotix has invested in a peer-reviewed clinical evidence program, with published studies documenting reductions in microbial burden and surgical site infection rates at deploying institutions.

Aerobiotix pursues a capital-equipment-plus-recurring-consumables business model, selling devices to hospital systems while generating recurring revenue through replacement filters, maintenance contracts, and service agreements. The company goes to market through a combination of direct enterprise sales and healthcare group purchasing organizations (GPOs) and channel partners including Vizient, CapstoneHealth, and PartnersCooperative. Disclosed backers include Vivo Capital, Asahi Kasei Ventures, and Horizon Technology Finance, with cumulative disclosed funding of approximately $35 million raised between 2021 and 2022.

Short descriptiontext

Aerobiotix develops FDA-cleared medical-grade air disinfection systems for hospitals and surgical suites, combining HEPA filtration with UVGI photolytic chamber technology. It sells to U.S. IDNs, academic medical centers, and federal healthcare facilities via direct sales and GPO channels.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMiamisburg, United States
HQ citystring
Miamisburg
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical air disinfection, surgical air purification, HEPA filtration systems, UVGI air treatment, hospital infection prevention
Industry4 codes
PRIMARYHLAHANAK
Air Quality & Environmental Infection Control (HEPA Filtration, Isolation Barriers, CSSD/HVAC Solutions)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables
SECONDARYHLAHANAD
Disinfection & Surface Decontamination (Wipes, Sprays, Fogging, UV Robots)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables
SECONDARYHSAEAHAC
Healthcare Facility & Medical Office Disinfection
Home & Personal Services/Home Cleaning & Housekeeping/Disinfection/Sanitization & Biohazard Cleaning
SECONDARYHSAEAHAF
Infectious Disease/Pathogen Decontamination
Home & Personal Services/Home Cleaning & Housekeeping/Disinfection/Sanitization & Biohazard Cleaning
NAICS code3 codes
  • Industrial and Commercial Fan and Blower and Air Purification Equipment Manufacturing333413
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
SIC code3 codes
  • Industrial & Commercial Fans & Blowers & Air Purifing Equip3564
  • Surgical & Medical Instruments & Apparatus3841
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Medical Air Disinfection Systems
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Air Disinfection Hardware Sales
TypeHardware Sales
Description

Sale of air disinfection devices (Illuvia Sense, AeroCure Vac, AeroCure 200, GermZone Pro) as capital equipment. Devices are FDA-registered Class II medical devices sold directly to healthcare facilities through enterprise sales motion, GPO contracts, and IDN partnerships. One-time capital purchase model.

aerobiotix.com
2Recurring Consumables & Service
TypeSubscription Recurring
Description

Recurring revenue from disposable pre-filter cartridge replacements (daily), periodic HEPA filter replacement, and UV lamp replacement performed by Aerobiotix representatives. Routine exterior wipe-down with EPA-registered disinfectant is performed by facility staff.

aerobiotix.com
3Professional Services & Training
TypeProfessional Services
Description

Competency-based staff training (approximately 30 minutes per session) included as part of implementation. Ongoing support from Aerobiotix Clean Air Consultants and sales representatives.

aerobiotix.com
Marketing channels16 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Operations, Supply Chain, Personnel, Marketing or Sales, Infrastructure
Pricing details1 tier
1Free In-Facility Trial
ModelFreemiumBilling cadencePay-as-you-go
Notes

Complimentary in-facility trial of Illuvia Sense including installation, baseline vs. active air quality metrics collection, and an Air Quality Assessment Report. No cost to the facility during the evaluation period.

aerobiotix.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Illuvia Sense
Description

Surgical air purification device with environmental sensing and reporting technologies, labeled for reducing risk of infection and improving environmental safety in operating rooms.

aerobiotix.com
+3 more records
Core offering1 text field

Aerobiotix designs, manufactures, and sells FDA-registered Class II medical air disinfection devices for hospitals and ambulatory surgery centers. The flagship Illuvia Sense system combines HEPA filtration, UVGI, and a proprietary Intraviolet photolytic chamber to continuously inactivate airborne bacteria, viruses, and spores in occupied operating rooms, with integrated real-time environmental sensing. Supporting products AeroCure Vac, AeroCure 200, and GermZone Pro extend air decontamination to other healthcare environments.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Inactivates 99.9% of bacteria, viruses, and spores in the air
+4 more records
Product overview1 text field

Aerobiotix offers a suite of proprietary medical-grade air disinfection products for healthcare environments. The core product is the Illuvia Sense system, an FDA-registered Class II medical device that provides continuous air decontamination with real-time environmental monitoring for operating rooms. Supporting the platform are additional air decontamination products including AeroCure Vac, AeroCure 200, and GermZone Pro. All products utilize ultraviolet light technology, HEPA or ULPA filters, and proprietary Intraviolet core technology to remove 99.9% of bacteria, viruses, and spores. The products are designed to run continuously in occupied rooms to reduce infection risks and improve patient and staff well-being.

Product and service6 records
1Illuvia Sense
CategoryMedical Air Disinfection — Surgical / Operating Room
Description

Illuvia Sense is an FDA-registered Class II medical device that provides continuous surgical air disinfection using HEPA filtration, ultraviolet germicidal irradiation (UVGI), and proprietary Intraviolet photolytic chamber technology. It delivers real-time environmental monitoring of particulate counts, temperature, humidity, door openings, CO2, and VOCs for operating rooms to reduce surgical site infections (SSIs) and improve environmental safety. Targets hospitals, ambulatory surgery centers, and surgical suites.

2AeroCure Vac
CategoryMedical Air Disinfection — Hospital
Description

AeroCure Vac is a hospital air disinfection system designed to eliminate airborne pathogens in healthcare facilities. Sold as part of Aerobiotix's hospital air decontamination product line.

3AeroCure 200
CategoryMedical Air Decontamination — Healthcare Facility
Description

AeroCure 200 is an air decontamination device for healthcare environments, utilizing Aerobiotix's proprietary ultraviolet and HEPA filtration technology to remove airborne pathogens.

4GermZone Pro
CategoryMedical Air Decontamination — Healthcare Facility
Description

GermZone Pro is an air decontamination system for healthcare facilities, part of Aerobiotix's portfolio of UV- and HEPA-based disinfection devices.

5Recurring Consumables & Service (Pre-filter cartridges, HEPA filters, UV lamp replacement)
CategoryService & Consumables — Medical Equipment
Description

Recurring revenue program delivering disposable pre-filter cartridge replacements (daily), periodic HEPA filter replacement, and UV lamp replacement performed by Aerobiotix representatives, plus routine exterior wipe-down with EPA-registered disinfectant. Bundled with device sales to support continuous operation of the air disinfection fleet.

6Professional Services & Training (Clean Air Consultants)
CategoryProfessional Services — Healthcare Training
Description

Competency-based staff training (approximately 30 minutes per session) included as part of device implementation, plus ongoing support from Aerobiotix Clean Air Consultants and sales representatives for healthcare facilities deploying Illuvia Sense and supporting devices.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-16
Description

Premier, Inc. awarded Aerobiotix USA, LLC a Technology Breakthrough Designation for Illuvia Sense, effective March 16, 2026. This designation enables Premier's member healthcare providers to access pre-negotiated pricing and terms for the infection prevention product. Premier is a leading healthcare improvement company operating a GPO serving thousands of US hospitals.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Listed as a GPO partner on Aerobiotix's Partnerships page, enabling member hospitals to procure Illuvia Sense through CapstoneHealth's group purchasing contracts.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Listed as a GPO partner on Aerobiotix's Partnerships page, providing group purchasing contracting for member healthcare facilities.

4International Respiratory Infections Society (IRIS)
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Aerobiotix co-developed the IRIS Healthcare Air Quality Seal of Recognition Program with the International Respiratory Infections Society. This program recognizes healthcare facilities that exceed established air quality standards in operating rooms, powered by Aerobiotix technology. The program is featured on safehealthcareair.org and included in Aerobiotix's marketing materials as a core differentiator.

aerobiotix.com
5AORN (Association of periOperative Registered Nurses)
Strategic tierCoreTypeGTM or Marketing Partner
Description

Aerobiotix is a member of AORN and actively sponsors chapter CE events (Chicago, Silicon Valley, Northeast Florida, San Francisco Bay Area) on air quality management, CMS TEAM model, and AORN sterile technique guidelines. Company presents at AORN 2026 Global Conference in New Orleans.

aerobiotix.com
Strategic tierCoreTypeGTM or Marketing Partner
Description

Aerobiotix is a member of APIC and sponsors chapter meetings and the APIC26 Annual Conference & Expo in Nashville. Educational content focuses on infection prevention, air quality management, and SSI reduction strategies.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Aerobiotix is a corporate member of AHVAP and sponsors the AHVAP 2026 Annual Conference & Industry Partner Expo. AHVAP authored a professional position statement on product evaluation that Aerobiotix references in its value analysis selling motion.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1IQAir
TypeBroad incumbent
Description

IQAir manufactures high-performance HEPA air purifiers used in hospitals, cleanrooms, and clinical settings. It competes with Aerobiotix in healthcare-grade air purification, though it relies on HEPA-only filtration rather than Aerobiotix's combined UVGI + photolytic chamber approach.

TypeDirect peer
Description

Novaerus (defunct brand Wellair) sells medical-grade plasma air disinfection units for healthcare and life science settings. It directly competes with Aerobiotix in operating rooms, ICUs, and patient rooms using an alternative (non-UV) air disinfection modality, making it the closest direct competitor.

3Abatement Technologies
TypeDirect peer
Description

Abatement Technologies manufactures HEPA-filtered air purification and negative-pressure containment equipment for healthcare facilities, including infection control during construction. It is comparable to Aerobiotix in addressing healthcare airborne pathogen control via portable HEPA-based devices.

4Steris
TypeBroad incumbent
Description

Steris is a global leader in infection prevention and sterilization, offering capital equipment and consumables to hospitals and surgical centers. It competes broadly with Aerobiotix in OR infection control via its sterilization and surface disinfection portfolio and represents a likely strategic acquirer.

TypeDirect peer
Description

Xenex manufactures pulsed-xenon UV disinfection robots used in hospital rooms for pathogen reduction. While its modality (mobile UV robot) differs from Aerobiotix's continuous in-room UVGI, it competes for the same SSI/HAI reduction budget within infection prevention departments.

TypeDirect peer
Description

AtmosAir Solutions provides commercial and healthcare indoor air quality solutions, including bipolar ionization and HEPA-based systems deployed in hospitals. It overlaps with Aerobiotix in the healthcare air disinfection category with comparable target customers (IDNs, hospitals).

TypeBroad incumbent
Description

Halton provides indoor air solutions for healthcare, including operating room ventilation, ULPA filtration, and air distribution systems. It is a broader incumbent in the surgical air quality infrastructure category, offering engineered HVAC versus Aerobiotix's point-of-care medical device approach.

TypeBroad incumbent
Description

Daikin Applied supplies commercial and healthcare HVAC systems, including filtration and air-handling units for hospital operating rooms. As a broad incumbent in OR ventilation, it represents the installed-base alternative to point-of-care devices like Aerobiotix's Illuvia Sense.

TypeDirect peer
Description

PDI's Tru-D SmartUVC platform provides UV-C disinfection for healthcare environments, primarily terminal room cleaning. It competes with Aerobiotix in the healthcare UV air/surface disinfection category, though it focuses more on room turnover than continuous in-OR air quality.

TypeDirect peer
Description

Surgically Clean Air markets medical-grade HEPA + UV air purification systems explicitly for operating rooms and surgical centers. It competes head-to-head with Aerobiotix in the surgical air quality category with a similar multi-stage HEPA/UV value proposition.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers22 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aerobiotix

Medical Air Disinfection Systemsaerobiotix.com

Aerobiotix develops FDA-cleared medical-grade air disinfection systems for hospitals and surgical suites, combining HEPA filtration with UVGI photolytic chamber technology. It sells to U.S. IDNs, academic medical centers, and federal healthcare facilities via direct sales and GPO channels.

What Aerobiotix does

Aerobiotix is a medical device company founded in 2013 and headquartered in Miamisburg, Ohio, that develops air disinfection systems for healthcare facilities. The company targets hospital-acquired infection (HAI) reduction through continuous air decontamination in operating rooms, intensive care units, and other clinical environments. Its installed base spans large integrated delivery networks (IDNs), academic medical centers, and federal healthcare facilities, including the VA health system.

The company's flagship product is the Illuvia Sense system, an FDA-registered Class II medical device that combines high-efficiency particulate air (HEPA) filtration with ultraviolet germicidal irradiation (UVGI) inside a proprietary Intraviolet photolytic chamber. The platform continuously monitors air quality via onboard sensors and is engineered to inactivate airborne pathogens without disrupting clinical workflows. Aerobiotix has invested in a peer-reviewed clinical evidence program, with published studies documenting reductions in microbial burden and surgical site infection rates at deploying institutions.

Aerobiotix pursues a capital-equipment-plus-recurring-consumables business model, selling devices to hospital systems while generating recurring revenue through replacement filters, maintenance contracts, and service agreements. The company goes to market through a combination of direct enterprise sales and healthcare group purchasing organizations (GPOs) and channel partners including Vizient, CapstoneHealth, and PartnersCooperative. Disclosed backers include Vivo Capital, Asahi Kasei Ventures, and Horizon Technology Finance, with cumulative disclosed funding of approximately $35 million raised between 2021 and 2022.

Aerobiotix firmographics

Firmographics
Name
Aerobiotix
Legal name
Aerobiotix USA, LLC
Website
https://aerobiotix.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
Aerobiotix develops FDA-cleared medical-grade air disinfection systems for hospitals and surgical suites, combining HEPA filtration with UVGI photolytic chamber technology. It sells to U.S. IDNs, academic medical centers, and federal healthcare facilities via direct sales and GPO channels.
Ownership category
akta.pro rank

Aerobiotix industry classification

Industry
Product category
Medical Air Disinfection Systems
NAICS
Industrial and Commercial Fan and Blower and Air Purification Equipment Manufacturing (333413), Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Industrial & Commercial Fans & Blowers & Air Purifing Equip (3564), Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro industry
PRIMARYHLAHANAK
Air Quality & Environmental Infection Control (HEPA Filtration, Isolation Barriers, CSSD/HVAC Solutions)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables
SECONDARYHLAHANAD
Disinfection & Surface Decontamination (Wipes, Sprays, Fogging, UV Robots)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables
SECONDARYHSAEAHAC
Healthcare Facility & Medical Office Disinfection
Home & Personal Services/Home Cleaning & Housekeeping/Disinfection/Sanitization & Biohazard Cleaning
SECONDARYHSAEAHAF
Infectious Disease/Pathogen Decontamination
Home & Personal Services/Home Cleaning & Housekeeping/Disinfection/Sanitization & Biohazard Cleaning

Keywords

  • Medical air disinfection
  • Surgical air purification
  • HEPA filtration systems
  • UVGI air treatment
  • Hospital infection prevention

Where Aerobiotix is headquartered

Location

Headquarters

HQ city
Miamisburg
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Aerobiotix business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Supply Chain, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Air Disinfection Hardware Sales: Sale of air disinfection devices (Illuvia Sense, AeroCure Vac, AeroCure 200, GermZone Pro) as capital equipment. Devices are FDA-registered Class II medical devices sold directly to healthcare facilities through enterprise sales motion, GPO contracts, and IDN partnerships. One-time capital purchase model.
  2. Recurring Consumables & Service: Recurring revenue from disposable pre-filter cartridge replacements (daily), periodic HEPA filter replacement, and UV lamp replacement performed by Aerobiotix representatives. Routine exterior wipe-down with EPA-registered disinfectant is performed by facility staff.
  3. Professional Services & Training: Competency-based staff training (approximately 30 minutes per session) included as part of implementation. Ongoing support from Aerobiotix Clean Air Consultants and sales representatives.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goFree In-Facility Trial

Go-to-market motion2 records

Distribution channels3 records

Marketing channels16 records

Aerobiotix product offering

Product offering

Core offering

Aerobiotix designs, manufactures, and sells FDA-registered Class II medical air disinfection devices for hospitals and ambulatory surgery centers. The flagship Illuvia Sense system combines HEPA filtration, UVGI, and a proprietary Intraviolet photolytic chamber to continuously inactivate airborne bacteria, viruses, and spores in occupied operating rooms, with integrated real-time environmental sensing. Supporting products AeroCure Vac, AeroCure 200, and GermZone Pro extend air decontamination to other healthcare environments.

Product overview

Aerobiotix offers a suite of proprietary medical-grade air disinfection products for healthcare environments. The core product is the Illuvia Sense system, an FDA-registered Class II medical device that provides continuous air decontamination with real-time environmental monitoring for operating rooms. Supporting the platform are additional air decontamination products including AeroCure Vac, AeroCure 200, and GermZone Pro. All products utilize ultraviolet light technology, HEPA or ULPA filters, and proprietary Intraviolet core technology to remove 99.9% of bacteria, viruses, and spores. The products are designed to run continuously in occupied rooms to reduce infection risks and improve patient and staff well-being.

Differentiator

Problem solved

Functional benefit

Brands

  • Illuvia Sense: Surgical air purification device with environmental sensing and reporting technologies, labeled for reducing risk of infection and improving environmental safety in operating rooms.
  • AeroCure Vac
  • AeroCure 200
  • GermZone Pro

Products and services

  • Illuvia Sense Illuvia Sense is an FDA-registered Class II medical device that provides continuous surgical air disinfection using HEPA filtration, ultraviolet germicidal irradiation (UVGI), and proprietary Intraviolet photolytic chamber technology. It delivers real-time environmental monitoring of particulate counts, temperature, humidity, door openings, CO2, and VOCs for operating rooms to reduce surgical site infections (SSIs) and improve environmental safety. Targets hospitals, ambulatory surgery centers, and surgical suites.
  • AeroCure Vac AeroCure Vac is a hospital air disinfection system designed to eliminate airborne pathogens in healthcare facilities. Sold as part of Aerobiotix's hospital air decontamination product line.
  • AeroCure 200 AeroCure 200 is an air decontamination device for healthcare environments, utilizing Aerobiotix's proprietary ultraviolet and HEPA filtration technology to remove airborne pathogens.
  • GermZone Pro GermZone Pro is an air decontamination system for healthcare facilities, part of Aerobiotix's portfolio of UV- and HEPA-based disinfection devices.
  • Recurring Consumables & Service (Pre-filter cartridges, HEPA filters, UV lamp replacement) Recurring revenue program delivering disposable pre-filter cartridge replacements (daily), periodic HEPA filter replacement, and UV lamp replacement performed by Aerobiotix representatives, plus routine exterior wipe-down with EPA-registered disinfectant. Bundled with device sales to support continuous operation of the air disinfection fleet.
  • Professional Services & Training (Clean Air Consultants) Competency-based staff training (approximately 30 minutes per session) included as part of device implementation, plus ongoing support from Aerobiotix Clean Air Consultants and sales representatives for healthcare facilities deploying Illuvia Sense and supporting devices.

Quantifiable outcome

  • Inactivates 99.9% of bacteria, viruses, and spores in the air
  • +4 more outcomes

Companies that use Aerobiotix

Customer profile

Named customers22 records

Segments4 records

Ideal customer profiles3 records

Aerobiotix technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Aerobiotix partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered major, minor and core.

  • Premier, Inc.majorChannel Partner/ Reseller/ Distributor · 16 March 2026Premier, Inc. awarded Aerobiotix USA, LLC a Technology Breakthrough Designation for Illuvia Sense, effective March 16, 2026. This designation enables Premier's member healthcare providers to access pre-negotiated pricing and terms for the infection prevention product. Premier is a leading healthcare improvement company operating a GPO serving thousands of US hospitals.
  • CapstoneHealthminorChannel Partner/ Reseller/ DistributorListed as a GPO partner on Aerobiotix's Partnerships page, enabling member hospitals to procure Illuvia Sense through CapstoneHealth's group purchasing contracts.
  • PartnersCooperativeminorChannel Partner/ Reseller/ DistributorListed as a GPO partner on Aerobiotix's Partnerships page, providing group purchasing contracting for member healthcare facilities.
  • International Respiratory Infections Society (IRIS)majorStrategic or Co-development PartnerAerobiotix co-developed the IRIS Healthcare Air Quality Seal of Recognition Program with the International Respiratory Infections Society. This program recognizes healthcare facilities that exceed established air quality standards in operating rooms, powered by Aerobiotix technology. The program is featured on safehealthcareair.org and included in Aerobiotix's marketing materials as a core differentiator.
  • AORN (Association of periOperative Registered Nurses)coreGTM or Marketing PartnerAerobiotix is a member of AORN and actively sponsors chapter CE events (Chicago, Silicon Valley, Northeast Florida, San Francisco Bay Area) on air quality management, CMS TEAM model, and AORN sterile technique guidelines. Company presents at AORN 2026 Global Conference in New Orleans.
  • APIC (Association for Professionals in Infection Control and Epidemiology)coreGTM or Marketing PartnerAerobiotix is a member of APIC and sponsors chapter meetings and the APIC26 Annual Conference & Expo in Nashville. Educational content focuses on infection prevention, air quality management, and SSI reduction strategies.
  • AHVAP (Association of Healthcare Value Analysis Professionals)coreGTM or Marketing PartnerAerobiotix is a corporate member of AHVAP and sponsors the AHVAP 2026 Annual Conference & Industry Partner Expo. AHVAP authored a professional position statement on product evaluation that Aerobiotix references in its value analysis selling motion.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Aerobiotix competitors and assessment

Company assessment

Broad incumbents

  • IQAir: IQAir manufactures high-performance HEPA air purifiers used in hospitals, cleanrooms, and clinical settings. It competes with Aerobiotix in healthcare-grade air purification, though it relies on HEPA-only filtration rather than Aerobiotix's combined UVGI + photolytic chamber approach.
  • Steris: Steris is a global leader in infection prevention and sterilization, offering capital equipment and consumables to hospitals and surgical centers. It competes broadly with Aerobiotix in OR infection control via its sterilization and surface disinfection portfolio and represents a likely strategic acquirer.
  • Halton Group: Halton provides indoor air solutions for healthcare, including operating room ventilation, ULPA filtration, and air distribution systems. It is a broader incumbent in the surgical air quality infrastructure category, offering engineered HVAC versus Aerobiotix's point-of-care medical device approach.
  • Daikin Applied (Daikin Industries): Daikin Applied supplies commercial and healthcare HVAC systems, including filtration and air-handling units for hospital operating rooms. As a broad incumbent in OR ventilation, it represents the installed-base alternative to point-of-care devices like Aerobiotix's Illuvia Sense.

Direct peers

  • Novaerus (Wellair): Novaerus (defunct brand Wellair) sells medical-grade plasma air disinfection units for healthcare and life science settings. It directly competes with Aerobiotix in operating rooms, ICUs, and patient rooms using an alternative (non-UV) air disinfection modality, making it the closest direct competitor.
  • Abatement Technologies: Abatement Technologies manufactures HEPA-filtered air purification and negative-pressure containment equipment for healthcare facilities, including infection control during construction. It is comparable to Aerobiotix in addressing healthcare airborne pathogen control via portable HEPA-based devices.
  • Xenex Disinfection Services: Xenex manufactures pulsed-xenon UV disinfection robots used in hospital rooms for pathogen reduction. While its modality (mobile UV robot) differs from Aerobiotix's continuous in-room UVGI, it competes for the same SSI/HAI reduction budget within infection prevention departments.
  • AtmosAir Solutions: AtmosAir Solutions provides commercial and healthcare indoor air quality solutions, including bipolar ionization and HEPA-based systems deployed in hospitals. It overlaps with Aerobiotix in the healthcare air disinfection category with comparable target customers (IDNs, hospitals).
  • PDI Healthcare (Tru-D SmartUVC): PDI's Tru-D SmartUVC platform provides UV-C disinfection for healthcare environments, primarily terminal room cleaning. It competes with Aerobiotix in the healthcare UV air/surface disinfection category, though it focuses more on room turnover than continuous in-OR air quality.
  • Surgically Clean Air: Surgically Clean Air markets medical-grade HEPA + UV air purification systems explicitly for operating rooms and surgical centers. It competes head-to-head with Aerobiotix in the surgical air quality category with a similar multi-stage HEPA/UV value proposition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Aerobiotix social profiles

Digital presence

Aerobiotix financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aerobiotix leadership team

Management profile

Number of profiles

Profiles3 records

Aerobiotix funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aerobiotix M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aerobiotix

What does Aerobiotix do?

Aerobiotix designs, manufactures, and sells FDA-registered Class II medical air disinfection devices for hospitals and ambulatory surgery centers. The flagship Illuvia Sense system combines HEPA filtration, UVGI, and a proprietary Intraviolet photolytic chamber to continuously inactivate airborne bacteria, viruses, and spores in occupied operating rooms, with integrated real-time environmental sensing. Supporting products AeroCure Vac, AeroCure 200, and GermZone Pro extend air decontamination to other healthcare environments.

Is Aerobiotix a public or private company?

Aerobiotix is a private company. It is classified as venture growth investor backed and is currently operating.

When was Aerobiotix founded?

Aerobiotix was founded in 2013. It employs 11 to 50 people.

Where is Aerobiotix based?

Aerobiotix is headquartered in Miamisburg, United States, in the North America region.

How does Aerobiotix make money?

Three revenue lines are on record. Air Disinfection Hardware Sales are the primary driver. The others are recurring Consumables & Service and professional Services & Training.

Who are Aerobiotix's main competitors?

Broad incumbents on record are IQAir, Steris, Halton Group and Daikin Applied (Daikin Industries). Direct peers are Novaerus (Wellair), Abatement Technologies, Xenex Disinfection Services, AtmosAir Solutions, PDI Healthcare (Tru-D SmartUVC) and Surgically Clean Air.

Does Aerobiotix have an API?

No public API is recorded for Aerobiotix.

What industry is Aerobiotix in?

Aerobiotix's product category is Medical Air Disinfection Systems. Its primary akta.pro industry code is HLAHANAK, Air Quality & Environmental Infection Control (HEPA Filtration, Isolation Barriers, CSSD/HVAC Solutions), with a secondary code of HLAHANAD, Disinfection & Surface Decontamination (Wipes, Sprays, Fogging, UV Robots). Its NAICS code is 333413 and its SIC code is 3564.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AijournAerobiotix Awarded Technology Breakthrough Designation for Room Environment Infection Prevention Products with Premier, Inc.Aerobiotix USA, LLC has been awarded a Technology Breakthrough Designation by Premier, Inc. for its Illuvia Sense continuous air disinfection system, effective March 16, 2026. The designation enables Premier's member healthcare providers to access pre-negotiated pricing and terms for the infection prevention product, which uses HEPA filtration, UVGI, and integrated particle sensing to reduce airborne contaminants and surgical site infections. Multiple peer-reviewed clinical studies have validated the system's effectiveness in improving operating room air quality and patient safety.PR NewswireAerobiotix Supports Updates to AORN's Sterile Technique GuidelinesAerobiotix, LLC announced support for the updated AORN Sterile Technique Guidelines, effective April 18, 2024, which emphasize air quality management in surgical environments to reduce surgical site infections. The company's Illuvia Sense FDA-registered medical device aligns with the new guidelines and is designed to reduce airborne contaminants without disrupting hospital workflows. Aerobiotix is hosting a continuing education webinar on May 23, 2024, led by Dr. Hudson Garrett, to help healthcare professionals apply the guideline updates.PR NewswireHorizon Technology Finance Leads $10 Million Venture Loan to AerobiotixHorizon Technology Finance closed a $10 million venture loan facility to Aerobiotix, with Horizon funding $5 million and a private investment vehicle managed by its adviser providing the remaining $5 million. The funds will support Aerobiotix's general growth and working capital needs as it expands its air disinfection systems for healthcare and other facilities.FinSMEsAerobiotix Raises $25M in Growth Equity FinancingAerobiotix raised $25 million in growth equity financing led by Vivo Capital with participation from Asahi Kasei Ventures. The company plans to utilize these funds to accelerate sales, marketing, and new product development for its airborne infection control solutions.VC News DailyAerobiotix Raises $25M Growth EquityAerobiotix, a medical device company specializing in hospital-based air decontamination products, has raised $25 million in growth equity financing. The funding round was led by Vivo Capital with participation from Asahi Kasei Ventures. Founded in 2013, the company develops FDA 510(k) cleared products like the ILLUVIA operating-room system, which reduces bacterial and viral contamination including SARS-CoV-2 and other pathogens.Business Wire BlogAerobiotix Raises $25M Growth Equity Financing Led by Global Healthcare Investment Firm Vivo CapitalAerobiotix raised $25 million in growth equity financing led by Vivo Capital, with participation from Asahi Kasei Ventures. The funds will accelerate sales, marketing, and new product development. The company's infection control products are used in over 175 hospitals and long-term care facilities.LelezardAerobiotix lève 25 millions de dollars avec l'aide de Vivo Capital.Aerobiotix has raised $25 million in funding with the participation of Vivo Capital and Asahi Kasei Ventures to boost sales, marketing, and new product development. The capital will support the expansion of its FDA-approved hospital air purification systems, which are designed to reduce bacterial and viral contamination in healthcare settings.